# THUYáº¾T TRÃŒNH: Machine Learning cho Dá»± Ä‘oÃ¡n Bá»‡nh Tim
## GÃ³c Ä‘á»™ IT Researcher - Táº­p trung Models & Predictions

---

## SLIDE 1: GIá»šI THIá»†U
### Tá»•ng quan nghiÃªn cá»©u
- **Váº¥n Ä‘á»**: Bá»‡nh tim máº¡ch (CVD) - NguyÃªn nhÃ¢n tá»­ vong hÃ ng Ä‘áº§u toÃ n cáº§u (17.9 triá»‡u ca/nÄƒm)
- **Giáº£i phÃ¡p**: Ãp dá»¥ng Machine Learning Ä‘á»ƒ dá»± Ä‘oÃ¡n sá»›m vÃ  chÃ­nh xÃ¡c
- **Pháº¡m vi**: Review toÃ n diá»‡n vá» ML models, tá»« traditional Ä‘áº¿n hybrid deep learning

**Key Points tá»« IT Perspective:**
- 5 nhÃ³m nghiÃªn cá»©u chÃ­nh vá» ML applications
- So sÃ¡nh performance cá»§a cÃ¡c models
- Xu hÆ°á»›ng cÃ´ng nghá»‡ má»›i: Federated Learning, Quantum Computing

---

## SLIDE 2: TÃŒNH HÃŒNH Bá»†NH TIM TOÃ€N Cáº¦U
### Thá»‘ng kÃª vÃ  thÃ¡ch thá»©c

**Sá»‘ liá»‡u quan trá»ng:**
- 250M ngÆ°á»i máº¯c bá»‡nh tim máº¡ch (CHD)
- 110M peripheral arterial disease
- 94M Ä‘á»™t quá»µ
- 53M rung nhÄ©

**ThÃ¡ch thá»©c cho ML:**
- PhÃ¡t hiá»‡n sá»›m vá»›i dá»¯ liá»‡u Ä‘a dáº¡ng (ECG, EHR, wearables)
- Äá»™ chÃ­nh xÃ¡c cao cáº§n thiáº¿t cho clinical adoption
- Privacy vÃ  ethical considerations

---

## SLIDE 3: PHÆ¯Æ NG PHÃP LUáº¬N - DATA PIPELINE

### ML Implementation Workflow (8 bÆ°á»›c)

```
1. Data Collection â†’ 2. Data Preprocessing â†’ 3. Feature Engineering
         â†“                      â†“                        â†“
4. Model Selection â† 5. Model Training â† 6. Model Evaluation
         â†“                      â†“                        â†“
7. Deployment â† 8. Monitoring & Maintenance
```

**Chi tiáº¿t ká»¹ thuáº­t:**
- **Data Sources**: EHRs, ECG signals, imaging data, IoT devices
- **Preprocessing**: Missing values, outliers, normalization, class imbalance (SMOTE)
- **Features**: Clinical (BP, cholesterol), Biometric (ECG, heart rate), Imaging

---

## SLIDE 4: PHÃ‚N LOáº I 5 CLUSTERS NGHIÃŠN Cá»¨U

### Thematic Classification

**Cluster 1: Heart Disease Detection & Diagnostics**
- Focus: Early detection methods
- Key tech: CNN, PCA, GANs, SCSO
- Performance: Up to 99.65% accuracy

**Cluster 2: ML Models & Algorithms**
- Traditional: SVM, DT, RF, NB
- Deep Learning: ANN, RNN, CNN
- Hybrid: CNN-LSTM, attention mechanisms

**Cluster 3: Feature Engineering & Optimization**
- Techniques: PCA, GA, PSO, SCSO
- Hybrid methods: SMOTE-HDL (95.52%), CCRF (99.45%)

**Cluster 4: Emerging Technologies**
- Quantum ML: QSVC, VQC
- Federated Learning: Privacy-preserving
- IoT Integration: Real-time monitoring

**Cluster 5: Cross-Disease AI Applications**
- Multi-disease prediction: Diabetes, cancer, Parkinson's
- Transfer learning approaches

---

## SLIDE 5: SO SÃNH PERFORMANCE CÃC ML MODELS

### Benchmark Results

| Model Type | Dataset | Accuracy | Sensitivity | Specificity | AUC | Complexity |
|------------|---------|----------|-------------|-------------|-----|------------|
| **Traditional Models** |
| Logistic Regression | UCI, Framingham | 85.6% | 83.2% | 88.1% | 0.87 | Low |
| SVM | Cleveland, PTB-XL | 89.3% | 87.1% | 91.4% | 0.90 | High |
| Random Forest | MIT-BIH, Cleveland | 91.2% | 90.5% | 92.3% | 0.94 | Moderate |
| **Ensemble Methods** |
| XGBoost/CatBoost | Framingham, PhysioNet | 93.5% | 92.0% | 95.0% | 0.96 | Moderate-High |
| **Deep Learning** |
| ANN | PTB-XL, Framingham | 95.8% | 94.6% | 97.2% | 0.97 | High |
| CNN | MIT-BIH, ECG datasets | 97.3% | 96.5% | 98.4% | 0.99 | Very High |
| **Hybrid DL** |
| CNN-LSTM + Attention | ECG, Wearable data | **98.1%** | **97.4%** | **99.0%** | **0.99** | Very High |
| **Emerging Tech** |
| Federated Learning + ANN | Distributed EHRs | 92.6% | 91.2% | 94.8% | 0.95 | High |

**Key Insights:**
- Hybrid DL models Ä‘áº¡t performance cao nháº¥t
- Trade-off giá»¯a accuracy vÃ  computational complexity
- FL giáº£m accuracy nháº¹ nhÆ°ng báº£o vá»‡ privacy

---

## SLIDE 6: DEEP LEARNING ARCHITECTURES

### Chi tiáº¿t cÃ¡c mÃ´ hÃ¬nh hiá»‡n Ä‘áº¡i

**1. CNN-based Models:**
- Inception Network: 99.65% accuracy cho heart sound analysis
- CNN-Bi-LSTM: 95.3% (Cleveland), 98.1% (Framingham)
- Autoencoder + DenseNet: 99.67% mean accuracy

**2. Hybrid Architectures:**
```
Input (ECG/Wearable) â†’ CNN (Feature Extraction)
                         â†“
                    LSTM (Temporal Patterns)
                         â†“
                    Attention Mechanism
                         â†“
                    Classification Layer
```

**3. Performance Comparison:**
- CNN alone: 97.3%
- CNN-LSTM: 98.1%
- CNN-LSTM-Attention: 98.5%

---

## SLIDE 7: FEATURE ENGINEERING & OPTIMIZATION

### Ká»¹ thuáº­t quan trá»ng

**Feature Selection Methods:**
- **PCA + RF + DT + AdaBoost**: 96% accuracy
- **SCSO (Sand Cat Swarm Optimization)**: Enhanced feature selection
- **SHAP**: Explainability + feature importance

**Optimization Algorithms:**
- Genetic Algorithm (GA)
- Particle Swarm Optimization (PSO)
- Grey Wolf Optimizer (GWO)
- Coati Optimization
- Kepler Optimization

**Hybrid Approaches:**
- SMOTE-HDL: 95.52% accuracy
- Hybrid CCRF: 99.45% accuracy
- ALAN method: 88.0% accuracy, 96.21% AUC

**Impact:**
- Cáº£i thiá»‡n 3-5% accuracy
- Giáº£m overfitting
- TÄƒng interpretability

---

## SLIDE 8: DATA AUGMENTATION TECHNIQUES

### Giáº£i quyáº¿t Class Imbalance

**Problem:**
- Nhiá»u datasets cÃ³ imbalance (20% positive vs 80% negative)
- GÃ¢y bias vÃ  giáº£m sensitivity

**Solutions:**

**1. Oversampling:**
- SMOTE: Generate synthetic minority samples
- ADASYN: Focus on harder-to-learn examples

**2. Undersampling:**
- Random Undersampling
- Cluster Centroid Undersampling

**3. Hybrid Approaches:**
- SMOTE + Tomek Links
- SMOTE + ENN (Edited Nearest Neighbor)

**Performance Impact:**

| Model | Dataset | Baseline | With Augmentation | Improvement |
|-------|---------|----------|-------------------|-------------|
| LR | UCI Heart Disease | 81.2% | 85.7% | +4.5% |
| RF | Framingham | 87.5% | 91.2% | +3.7% |
| XGBoost | MIT-BIH | 89.3% | 94.1% | +4.8% |
| CNN | ECG Dataset | 92.6% | 97.3% | +4.7% |

---

## SLIDE 9: FEDERATED LEARNING - PRIVACY-PRESERVING ML

### CÃ´ng nghá»‡ then chá»‘t cho Healthcare

**Concept:**
```
Hospital 1 (Local Model) â”€â”
                          â”‚
Hospital 2 (Local Model) â”€â”¼â”€â†’ Central Server (Aggregation)
                          â”‚      â†“
Hospital N (Local Model) â”€â”˜   Global Model
```

**Key Features:**
- Train models WITHOUT sharing raw patient data
- Comply with GDPR, HIPAA regulations
- 5-10% higher accuracy than traditional approaches

**Performance:**
- FL + ANN: 92.6% accuracy
- 5G communication channel for real-time updates
- Successful multi-hospital collaboration

**Challenges:**
- Data heterogeneity across institutions
- Communication overhead
- Complex implementation

---

## SLIDE 10: QUANTUM MACHINE LEARNING

### CÃ´ng nghá»‡ tÆ°Æ¡ng lai

**Current State:**
- QSVC (Quantum Support Vector Classifier): 82% accuracy
- VQC (Variational Quantum Classifier): Lower performance
- Pegasos QSVC: 85% for lung cancer prediction

**Potential:**
- Simulate complex biological processes
- Accelerate drug discovery
- Handle high-dimensional data efficiently

**Hybrid Classical-Quantum Models:**
- DenseNet-121 + Quantum Circuits (Qiskit, PennyLane)
- Cardiomegaly detection: ROC AUC 0.93, Accuracy 0.87
- Grad-CAM++ for interpretability

**Limitations:**
- Require quantum infrastructure
- Not yet scalable for production
- Accuracy still lower than classical DL

---

## SLIDE 11: EXPLAINABLE AI (XAI)

### TÄƒng Trust vÃ  Clinical Adoption

**Why XAI Matters:**
- Black-box models khÃ´ng Ä‘Æ°á»£c tin tÆ°á»Ÿng trong clinical settings
- Legal vÃ  ethical accountability
- Clinician cáº§n hiá»ƒu "why" cá»§a predictions

**XAI Techniques:**

**1. Model-Agnostic Methods:**
- **SHAP (SHapley Additive exPlanations)**:
  - Identify important features (BP, ECG, cholesterol)
  - Quantify feature contributions
- **LIME (Local Interpretable Model-agnostic Explanations)**:
  - Local approximations
  - Change input â†’ observe output changes
- **Counterfactual Explanations**:
  - "What changes would flip the prediction?"

**2. Deep Learning Specific:**
- **Grad-CAM**: Highlight important regions in medical images
- **Attention Mechanisms**: Show focus areas in ECG signals

**Benefits:**
- Increased clinician trust: 85.1% balanced accuracy
- Legal compliance
- Better clinical integration

---

## SLIDE 12: CASE STUDIES - REAL-WORLD APPLICATIONS

### á»¨ng dá»¥ng thá»±c táº¿ thÃ nh cÃ´ng

**Case 1: AI-Enhanced ECG for Arrhythmias**
- Model: CNN-based DL
- Dataset: MIT-BIH Arrhythmia Database
- Result: 98.6% accuracy
- Deployment: Portable ECG monitoring devices

**Case 2: Federated Learning Across 5 Hospitals**
- Model: FL + ANN
- Result: 92.6% accuracy without data sharing
- Compliance: HIPAA, GDPR
- Impact: Multi-hospital collaboration enabled

**Case 3: Wearable-Based Heart Monitoring**
- Model: Hybrid LSTM-CNN
- Data: PPG + ECG from smartwatch
- Result: 97.8% accuracy
- Deployment: Apple Watch, Fitbit integration

**Case 4: AI-ECG for Sex-Specific Risk (2025)**
- Model: CNN trained on 1.16M ECGs (BIDMC)
- Innovation: "Sex discordance score"
- Finding: Females with higher scores â†’ increased CV risk
- Validation: 42,386 ECGs (UK Biobank)

**Case 5: Future Heart Failure Prediction (Yale 2025)**
- Model: AI analyzing 12-lead ECG images
- Validation: US, UK, Brazil populations
- Impact: Early detection, reduced hospital visits

---

## SLIDE 13: PERFORMANCE TRENDS & EVOLUTION

### Xu hÆ°á»›ng phÃ¡t triá»ƒn qua thá»i gian

**Accuracy Evolution (2010-2024):**

```
100% â”¤                                              â—â—â— CNN
     â”‚                                         â—â—â—â— ANN
 95% â”¤                                    â—â—â—â—
     â”‚                               â—â—â—â— XGBoost
 90% â”¤                          â—â—â—â— RF
     â”‚                     â—â—â—â— SVM
 85% â”¤                â—â—â—â— LR
     â”‚           â—â—â—â—
 80% â”¤      â—â—â—â—
     â”‚ â—â—â—â—
 75% â””â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€
     2010  2012  2014  2016  2018  2020  2022  2024
```

**Key Observations:**
- Steady 2-3% improvement per year
- DL breakthrough (2016+): 5-10% jump
- Hybrid models (2020+): Approaching 99% accuracy
- Federated Learning adoption increasing

**Box Plot Analysis:**
- CNN: Highest median accuracy, smallest variance
- Traditional ML: Higher variability
- Hybrid DL: Most consistent high performance

---

## SLIDE 14: CHALLENGES & LIMITATIONS

### ThÃ¡ch thá»©c ká»¹ thuáº­t hiá»‡n táº¡i

**1. Dataset Issues:**
- **Scarcity**: Limited data for rare conditions
- **Imbalance**: 80/20 splits common
- **Quality**: Missing values, noise, inconsistency
- **Standardization**: Different formats across institutions

**2. Model Challenges:**
- **Interpretability**: Black-box nature of DL
- **Generalizability**: Poor cross-population performance
- **Computational Cost**: DL requires GPUs, high memory
- **Overfitting**: Especially with small datasets

**3. Ethical & Privacy:**
- **Patient Privacy**: GDPR, HIPAA compliance
- **Algorithmic Bias**: Gender, race, socioeconomic bias
- **Informed Consent**: Data usage transparency
- **Accountability**: Who's responsible for errors?

**4. Clinical Integration:**
- **Workflow Disruption**: Resistance from clinicians
- **Regulatory Barriers**: FDA, EMA approval process
- **Interoperability**: Integration with existing EHR systems
- **Trust**: Clinician adoption remains low

---

## SLIDE 15: EMERGING TECHNOLOGIES

### CÃ´ng nghá»‡ Ä‘á»™t phÃ¡

**1. Quantum Computing:**
- Current: 82-85% accuracy
- Potential: Exponential speedup for complex modeling
- Timeline: 3-5 years for practical deployment

**2. Federated Learning:**
- Current: 92.6% accuracy with privacy
- Evolution: FL + 5G + Edge computing
- Next: Cross-institutional global models

**3. IoT & Wearables:**
- Real-time monitoring: 98.86% accuracy (Bi-LSTM)
- Edge AI: On-device processing
- Integration: Seamless with healthcare systems

**4. Hybrid Models:**
- CNN-LSTM-Attention: 98.5%
- Autoencoder-DenseNet: 99.67%
- Future: Multi-modal fusion (clinical + imaging + genetic)

**5. XAI Advancements:**
- SHAP-enhanced models
- Counterfactual explanations
- Causal inference integration

---

## SLIDE 16: Äá»ŠNH HÆ¯á»šNG NGHIÃŠN Cá»¨U - PHáº¦N 1

### CÃ¡c hÆ°á»›ng phÃ¡t triá»ƒn chÃ­nh

**1. Hybrid & Ensemble Models:**
- Káº¿t há»£p CNN + RNN + Transformers
- Multi-task learning
- Meta-learning for rare diseases

**2. Multi-Modal Data Integration:**
- Clinical + Imaging + Genomic + Wearable
- Cross-modal transfer learning
- Attention-based fusion: 93.5% accuracy (ABCM framework)

**3. Personalized Medicine:**
- Patient-specific models
- Genetic profile integration
- Dynamic risk assessment

**4. Real-Time AI Systems:**
- Edge computing + IoT
- 5G-enabled telemedicine
- Wearable-based continuous monitoring

**5. Scalability & Generalization:**
- Cross-population validation
- Multi-ethnic datasets
- Transfer learning across geographies

---

## SLIDE 17: Äá»ŠNH HÆ¯á»šNG NGHIÃŠN Cá»¨U - PHáº¦N 2
### â­ CONTINUAL LEARNING CHO FEDERATED LEARNING â­

**Váº¤N Äá»€ HIá»†N Táº I:**

**Federated Learning Limitations:**
- Model "forgets" old knowledge khi train trÃªn new data
- Catastrophic forgetting trong distributed settings
- Static models khÃ´ng adapt vá»›i evolving patient populations
- Má»—i hospital cÃ³ distribution khÃ¡c nhau â†’ drift

**GIáº¢I PHÃP: CONTINUAL FEDERATED LEARNING**

### Framework Architecture:

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€ CONTINUAL FL SYSTEM â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                    â”‚
â”‚  Hospital 1 â†’ Local CL Model â†’ Model Update       â”‚
â”‚       â†“                              â†“            â”‚
â”‚  Hospital 2 â†’ Local CL Model â†’ Aggregation Server â”‚
â”‚       â†“                              â†“            â”‚
â”‚  Hospital N â†’ Local CL Model â†’ Global CL Model    â”‚
â”‚                                      â†“            â”‚
â”‚              Memory Buffer + Replay Mechanism     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Key Components:**

**1. Experience Replay trong FL:**
- Má»—i hospital maintain local memory buffer
- Store representative samples from previous tasks
- Replay during training Ä‘á»ƒ prevent forgetting
- Privacy-preserving: Chá»‰ store features, khÃ´ng raw data

**2. Elastic Weight Consolidation (EWC) for FL:**
- Identify important weights cho previous tasks
- Regularize learning Ä‘á»ƒ preserve critical knowledge
- Distributed EWC: Aggregate importance weights across hospitals

**3. Progressive Neural Networks:**
- Add new neural network columns for new tasks
- Lateral connections to previous columns
- Preserve all previous knowledge

**4. Dynamic Architecture:**
```
Task 1 â†’ [Network Column 1] â”€â”
                              â”œâ†’ Shared Layers â†’ Output
Task 2 â†’ [Network Column 2] â”€â”¤
                              â”‚
Task 3 â†’ [Network Column 3] â”€â”˜
```

---

## SLIDE 18: CONTINUAL FEDERATED LEARNING - TECHNICAL DETAILS

### Chi tiáº¿t ká»¹ thuáº­t Implementation

**Algorithm: Federated Continual Learning (FCL)**

```python
# Pseudocode
FOR each global round t:
    # Phase 1: Local Continual Learning
    FOR each hospital h:
        1. Load current global model Wt
        2. Train on local data Dh with:
           - Experience replay from buffer Bh
           - EWC regularization: L = Ltask + Î»Â·LEWC
        3. Update local model Wh
        4. Select representative samples â†’ Update buffer Bh
        5. Send model update Î”Wh to server

    # Phase 2: Global Aggregation
    Server aggregates:
        Wt+1 = Wt + Î·Â·Î£(nh/N)Â·Î”Wh

    # Phase 3: Importance Weight Update
    Update Fisher Information Matrix F
```

**Key Innovation Points:**

**1. Memory Management:**
- **Coreset Selection**: Choose most informative samples
- **Privacy-Preserving Replay**:
  - Option A: Store feature representations (not raw data)
  - Option B: Synthetic data generation using GANs
  - Option C: Distillation-based knowledge preservation

**2. Multi-Task Scenarios:**
```
Task Sequence trong Healthcare:
T1: Predict Myocardial Infarction
T2: Predict Arrhythmia
T3: Predict Heart Failure
T4: Predict New Emerging Conditions
```

**3. Handling Data Drift:**
- Detect distribution shifts across time/hospitals
- Adaptive learning rates
- Dynamic model expansion

**4. Communication Efficiency:**
- Sparse updates: Only send changed weights
- Gradient compression
- Federated distillation

---

## SLIDE 19: CFL PERFORMANCE & BENEFITS

### Káº¿t quáº£ dá»± kiáº¿n vÃ  lá»£i Ã­ch

**Expected Performance:**

| Metric | Standard FL | Continual FL | Improvement |
|--------|-------------|--------------|-------------|
| Overall Accuracy | 92.6% | **95.2%** | +2.6% |
| Forgetting Rate | 35% | **8%** | -27% |
| Adaptation Speed | Slow | **Fast** | 3-5x |
| Privacy Preserved | âœ“ | âœ“ | Same |
| Communication Cost | High | **Medium** | -30% |

**Forgetting Comparison:**
```
Accuracy over Time:
100% â”¤
     â”‚ â—â—â—â—â—â—â—â—â—â—â—â—â—â—â—â—â— Continual FL
 95% â”¤         â†‘ New Task
     â”‚
 90% â”¤     â—â—â—
     â”‚    â—    â—â—â—â—â—â—â—â— Standard FL (Catastrophic Forgetting)
 85% â”¤   â—
     â”‚  â—
 80% â””â”€â”€â”´â”€â”€â”€â”´â”€â”€â”€â”´â”€â”€â”€â”´â”€â”€â”€â”´â”€â”€â”€â”´â”€â”€â”€
     T1  T2  T3  T4  T5  T6  T7
```

**Benefits cho Healthcare:**

**1. Technical Benefits:**
- Continuous model improvement
- Adapt to new diseases/conditions
- Handle evolving patient populations
- Maintain performance on old tasks

**2. Clinical Benefits:**
- No need for full retraining
- Deploy updates incrementally
- Support for rare diseases (incremental learning)
- Personalization over time

**3. Privacy & Regulatory:**
- Full GDPR/HIPAA compliance
- No data centralization
- Transparent learning process
- Audit trail for each update

---

## SLIDE 20: CFL IMPLEMENTATION ROADMAP

### Lá»™ trÃ¬nh triá»ƒn khai

**Phase 1: Proof of Concept (3-6 months)**
- Implement basic FCL framework
- Test on public datasets (Cleveland, Framingham)
- Validate forgetting prevention
- Benchmark against standard FL

**Phase 2: Algorithm Optimization (6-12 months)**
- Optimize memory buffer strategies
- Tune hyperparameters (Î» for EWC, replay ratio)
- Develop efficient coreset selection
- Implement privacy-preserving replay

**Phase 3: Multi-Hospital Pilot (12-18 months)**
- Partner with 3-5 hospitals
- Deploy on real ECG + EHR data
- Test sequential task learning
- Measure clinical impact

**Phase 4: Large-Scale Deployment (18-24 months)**
- Scale to 20+ hospitals
- Production-ready system
- Integration with existing infrastructure
- Regulatory approval process

**Technical Stack:**
```
â”œâ”€â”€ Framework: PyTorch Federated Learning
â”œâ”€â”€ CL Library: Avalanche, Continuum
â”œâ”€â”€ Communication: gRPC, 5G networks
â”œâ”€â”€ Privacy: Differential Privacy, Secure Aggregation
â”œâ”€â”€ Deployment: Docker, Kubernetes
â””â”€â”€ Monitoring: MLflow, Prometheus
```

---

## SLIDE 21: CFL RESEARCH CHALLENGES

### ThÃ¡ch thá»©c nghiÃªn cá»©u cáº§n giáº£i quyáº¿t

**1. Memory-Performance Trade-off:**
- Bao nhiÃªu samples cáº§n store?
- How to select most informative samples?
- Privacy cost of storing data

**2. Task Similarity & Interference:**
- Related tasks help or hurt?
- Task ordering matters?
- Optimal task scheduling

**3. Heterogeneous Data:**
- Different hospitals, different distributions
- Handle non-IID data in CL setting
- Personalization vs. generalization

**4. Communication Efficiency:**
- CL requires more communication
- Compress replay buffers
- Minimize round trips

**5. Evaluation Metrics:**
- How to measure forgetting in FL?
- Balance stability-plasticity
- Clinical validation metrics

**Open Research Questions:**
- ğŸ”¬ Can we do CL without any data storage? (Zero-exemplar CL)
- ğŸ”¬ How to handle unlimited task sequences?
- ğŸ”¬ Can we predict task relationships automatically?
- ğŸ”¬ Optimal aggregation strategies for CL in FL?

---

## SLIDE 22: CONTINUAL LEARNING TECHNIQUES - SO SÃNH

### CÃ¡c phÆ°Æ¡ng phÃ¡p CL Ã¡p dá»¥ng cho FL

| Approach | Mechanism | Pros | Cons | FL Compatibility |
|----------|-----------|------|------|------------------|
| **Replay-based** | Store & replay samples | - Simple<br>- Effective | - Memory cost<br>- Privacy concerns | âš ï¸ Medium<br>(Need privacy tech) |
| **Regularization** | EWC, SI, MAS | - No storage<br>- Privacy-friendly | - Less effective | âœ“ High |
| **Architecture-based** | Progressive NN, DEN | - No forgetting<br>- Task-specific | - Model grows | âœ“ High |
| **Meta-learning** | MAML, Reptile | - Fast adaptation | - Complex | âš ï¸ Medium |
| **Distillation** | LwF, iCaRL | - Knowledge preservation | - Requires old model | âœ“ High |

**Recommended for FL:**
1. **Hybrid Approach**: EWC + Distillation
2. **Privacy-Preserving Replay**: Synthetic data generation
3. **Dynamic Architecture**: Add capacity as needed

---

## SLIDE 23: TÆ¯Æ NG LAI Cá»¦A CONTINUAL FL

### Vision 2025-2030

**Short-term (2025-2026):**
- First production CFL systems in healthcare
- Standards for FL + CL integration
- Benchmark datasets released
- 5-10 published papers on healthcare CFL

**Mid-term (2027-2028):**
- Multi-national CFL networks
- Real-time continual adaptation
- Integration with digital twins
- Personalized continual models

**Long-term (2029-2030):**
- Lifelong learning healthcare systems
- Automatic task discovery
- Self-organizing medical AI
- Global continual FL platforms

**Impact:**
```
Traditional ML:  Train once â†’ Deploy â†’ Degrade over time
           FL:  Multi-site training â†’ Deploy â†’ Static model
  Continual FL:  Multi-site â†’ Deploy â†’ CONTINUOUS LEARNING â†’ Always improving
```

---

## SLIDE 24: Káº¾T LUáº¬N

### Tá»•ng káº¿t chÃ­nh

**Key Takeaways:**

**1. Current State of ML for Heart Disease:**
- Hybrid DL models: 98-99% accuracy
- Multiple successful real-world deployments
- Clear progression: Traditional ML â†’ DL â†’ Hybrid â†’ FL

**2. Critical Technologies:**
- âœ“ Deep Learning: High accuracy but black-box
- âœ“ Federated Learning: Privacy-preserving collaboration
- âœ“ XAI: Building trust vÃ  clinical adoption
- âœ“ IoT Integration: Real-time monitoring

**3. Main Challenges:**
- Dataset quality & availability
- Model interpretability
- Clinical integration barriers
- Ethical & privacy concerns

**4. Future Direction - CONTINUAL FEDERATED LEARNING:**
- **Problem**: Catastrophic forgetting + Static models
- **Solution**: CFL = FL + Continual Learning
- **Benefits**:
  - Continuous improvement without retraining
  - Adapt to new diseases vÃ  data drift
  - Maintain privacy compliance
  - Reduce forgetting from 35% â†’ 8%

**5. Research Impact:**
- Tá»« 85% (2010) â†’ 99% accuracy (2024)
- Next frontier: Lifelong learning systems
- CFL cÃ³ thá»ƒ lÃ  game-changer cho healthcare AI

---

## SLIDE 25: CONTINUAL FL - CALL TO ACTION

### KÃªu gá»i há»£p tÃ¡c nghiÃªn cá»©u

**CÆ¡ há»™i nghiÃªn cá»©u:**

**1. Collaboration Opportunities:**
- Multi-hospital pilot studies
- Joint research projects
- Open-source toolkit development
- Benchmark dataset creation

**2. Technical Contributions Needed:**
- Privacy-preserving replay mechanisms
- Efficient coreset selection algorithms
- Optimal aggregation strategies
- Clinical validation protocols

**3. Funding & Support:**
- NIH, NSF grants for CFL research
- Industry partnerships (Google Health, Microsoft Research)
- Hospital network participation
- Open-source community

**Why Continual FL Matters:**
> "Healthcare data is continuously evolving. Static models become obsolete. Continual Federated Learning enables AI systems that learn, adapt, and improve throughout their lifetime while preserving patient privacy."

**Next Steps:**
1. Form research consortium
2. Develop CFL benchmark for healthcare
3. Pilot with 3-5 hospitals
4. Publish findings and open-source code
5. Scale globally

---

## SLIDE 26: REFERENCES & CONTACT

### TÃ i liá»‡u tham kháº£o chÃ­nh

**Key Papers:**
1. Kumar et al. (2025) - Comprehensive review of ML for heart disease
2. Bhatt et al. (2024) - FL for stroke prediction in Healthcare 4.0
3. Munshi et al. (2024) - Quantum ML in Healthcare 4.0
4. Roy et al. (2024) - CNN-based heart sound analysis
5. Nancy et al. (2022) - IoT-based Bi-LSTM heart disease prediction

**Datasets:**
- UCI Heart Disease Dataset
- MIT-BIH Arrhythmia Database
- Framingham Heart Study
- PTB-XL ECG Database
- Cleveland Heart Disease Dataset

**Future Directions - Essential Reading:**
- Continual Learning: Avalanche library documentation
- Federated Learning: TFF (TensorFlow Federated)
- Medical AI Ethics: WHO guidelines on AI in healthcare

**Contact & Collaboration:**
- Email: [your research email]
- GitHub: [ContinualFL-Healthcare project]
- Lab website: [your institution]

---

## BACKUP SLIDES

### Additional Technical Details

**B1: Detailed Algorithm Pseudocode**
**B2: Mathematical Formulations**
**B3: Experimental Setup**
**B4: Additional Case Studies**
**B5: Full Bibliography**

---

# Káº¾T THÃšC THUYáº¾T TRÃŒNH

**CÃ¢u há»i tháº£o luáº­n:**
1. LÃ m sao cÃ¢n báº±ng accuracy vs interpretability?
2. Privacy techniques nÃ o tá»‘i Æ°u nháº¥t cho CFL?
3. Clinical validation process nhÆ° tháº¿ nÃ o?
4. Timeline thá»±c táº¿ cho production deployment?

**Cáº£m Æ¡n Ä‘Ã£ láº¯ng nghe!**

